Ever found it puzzling that a patient with more than 12 months of neoadjuvant chemotherapy flies trough postoperative recovery after major liver resection without any signs of chemotherapy associated steatohepatitis (CASH) on histology, while some patients after only 2 months of systemic therapy struggle significantly due to chemotherapy associated liver injury? Annals of Surgical Oncology is featuring our recent results on the non-invasive assessment of CASH using a combined score of routine lab parameters with an authors reflection.
https://lnkd.in/dxh7MQi Stay tuned for the smart phone App to allow easy calculation of this score in your daily routine.
